Watson Gets To Investigate FTC Communications With FDA After Discovery Ruling
This article was originally published in The Pink Sheet Daily
Executive Summary
A federal judge says the facts show "the strong possibility" that FTC tried to broker a deal between Watson and Apotex requiring Watson to give up its marketing exclusivity for generic Provigil.